Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIPIDO: ICG Visualisation in Ovarian Cancer Surgery
NCT04891185Phase 2Terminated
- Sponsor
- UZ Leuven
- Start
- Oct 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green in ovarian cancer, sponsored by UZ Leuven. Started Oct 2021; status: terminated.
02
Drugs
indocyanine green
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT04891185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04891185.